Articles - Page 10 of 69 - Drugs in Context

COVID-19-related adaptations to the implementation and evaluation of a clinic-based intervention designed to improve opioid safety

Anna R Morgan, Michelle A Hendricks, Sanae El Ibrahimi, Sara E Hallvik, Brigit Hatch, Caitlin Dickinson, Dagan Wright, Michael A Fischer

Article Type

Review

Published

15 Dec 2021

This article reviews a multidisciplinary project designed to implement and evaluate clinic-based interventions in Oregon, USA, to improve pain management, opioid prescribing and treatment of opioid use disorder.

SAFE – Home Opioid Management Education (SAFE-HOME) in older adults: a naloxone awareness program for home health workers

Brianna M McQuade, Mike Koronkowski, Erin Emery-Tiburcio, Robyn Golden, Jennie B Jarrett

Article Type

Original Research

Published

15 Dec 2021

This article discusses the SAFE – Home Opioid Management Education (SAFE-HOME) naloxone awareness program for older adults which utilizes home health workers to educate older adults who are prescribed opioid medications about the access to and use of naloxone to reverse opioid overdose.

Evaluating the effectiveness of problem-solving courts at preventing fatal and non-fatal opioid events: preliminary findings from Indiana

Elizabeth Van Nostrand, Alyssa Johnston, Steven M Albert, Andre L Brown, Jeanine M Buchanich, Brad Ray, Mark S Roberts

Article Type

Original Research

Published

15 Dec 2021

The aim of this study is to determine which interventions offered by problem-solving courts and correctional facilities impact morbidity and mortality of persons arrested for drug misuse.

Granulocyte and monocyte/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports

Ana Victoria Carro Martínez, Lydia Montolio Chiva, Montserrat Robustillo Villarino

Article Type

Case Report

Published

05 Nov 2021

We present four clinical reports that illustrate the clinical uses of GMA with the medical device Adacolumn® in patients with different backgrounds and immune-mediated inflammatory arthritis.

New and emerging lipid-modifying drugs to lower LDL cholesterol

Constantine E Kosmas, Dafni Pantou, Andreas Sourlas, Evangelia J Papakonstantinou, Rogers Echavarria Uceta, Eliscer Guzman

Article Type

Review

Published

01 Nov 2021

This review aims to present and discuss the current clinical and scientific data pertaining to the new and emerging lipid-modifying low-density lipoprotein-cholesterol-lowering drugs.